The International Society of Nephrology (ISN) is pleased to
announce the AMGEN, Inc. International Prize for Therapeutic
Advancement of Nephrology, which inaugurates recognition for those who
have increased the understanding and treatment of kidney disease through basic or clinical
scientific research leading to therapeutic advances.
This
prize is made possible by the generosity and vision of AMGEN, Inc. in Thousand Oaks,
California.
Each recipient will receive $50,000 US and a framed certificate with
an appropriate citation. Normally, the prize is to be awarded to a single individual. If
two individuals are selected, they will share the prize equally. The prize will be awarded
without restrictions to nationality, race, religion, or gender. An advisory committee
representing members of the ISN and AMGEN, Inc. will recommend recipients of the prize. To
be considered for the prize, nomination letters must be sent to the Advisory Committee
Chair, John H. Dirks, M.D., Massey College, 4 Devonshire Place, Toronto, Ontario, Canada,
M5S 2E1, e-mail: [email protected], Fax:
+1 416 946 3302.
Nomination letters must describe the basic or clinical scientific
role of the nominee and should be accompanied by a full curriculum vitae with a complete
mailing address and at least two supporting letters that detail the full nature and scope
of a major and sustained therapeutic advance.
Nominations must be received by Monday March 17, 2003,
to be considered for the initial round of selection.
The first prize will be presented at the ISN Congress in Berlin in
June, 2003, and, every 2 years thereafter at the Congress of the ISN through 2009.
Terms of reference
Back to ISN
Announcement page
Last update: 08-Jan-2003
|
